4917 Waters Edge Drive, Suite 275
Raleigh, NC 27606
2 Davis Drive
Durham, NC 27709
101 North Chestnut Street, Suite 103
Winston-Salem, NC 27101
The biotech patents group is international in scope, seeking patent protection on behalf of clients in many foreign jurisdictions. Additionally, the biotech patent practice advises clients on freedom to operate analysis and clearance for entry of new biotech products into the United States and foreign countries, as well in due diligence matters for intellectual property acquisition and monetization.
The technologies that we focus on include enzymes, proteins, diagnostic materials, kits, and devices, biological systems, chemical patents, genetically modified goods, biologics, agribusiness, and plant science.
Our biotechnology practice also includes advising clients on complex corporate, joint venture, and licensing matters as they arise, and the firm represents both investors and startup companies.
This biotech patent includes compositions and methods that are provided for enhanced production of ethanol from fermentation of tobacco biomass. Nicotine resistant microorganisms are provided, as well as methods for making these nicotine resistant microorganisms. A biologically pure culture is provided of a nicotine resistant Saccharomyces cerevisiae strain or a mutant thereof having all the identifying characteristics thereof. Methods are provided for producing ethanol from fermentation of tobacco biomass in which the nicotine resistant microorganisms are used in the fermentation of the tobacco biomass, wherein a higher amount of ethanol can be produced from the fermentation. The nicotine resistant yeast strains of the present disclosure can improve ethanol production in tobacco biomass extract fermentations and shorten the fermentation time.
This biotech patent refers to a composition comprising Bacillus subtilis (DSM 17231) and Bacillus licheniformis (DSM 17236) with nematocidal effect against phytonematodes on plants and/or its habitat, to its use and process for its preparation, use of Bacillus subtilis (DSM 17231) and Bacillus licheniformis (DSM 17236), processes for controlling, combating and conferring specific resistance to phytonematodes, and a kit.
Cell binding peptides are provided for binding to cells including urothelial and thyroid follicular cells. The peptides are useful for detection and diagnosis of cancer including bladder and thyroid cancer. A device and method for using the device for capturing cells is provided, the device includes a support having attached cell binding peptide. The support can be a slide and the device can be used for detection and diagnosis of cancer including bladder and thyroid cancer. A kit is provided with instructions for capturing cells and a support with attached cell binding peptide for detection and diagnosis of bladder and thyroid cancer.